What's in Baptist Health South Florida's pipeline?

Baptist Health South Florida has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Baptist Health South Florida's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/baptist-health-south-florida.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Baptist Health South Florida — Portfolio Competitive Intelligence Brief

Baptist Health South Florida pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
potassium chloride replacement	potassium chloride replacement	marketed	Electrolyte replacement / mineral supplement	Potassium ion (K+)	Electrolyte management / General medicine
Experimental - 4% Sodium Bicarbonate	Experimental - 4% Sodium Bicarbonate	marketed	Antacid / Alkalinizing agent		Gastroenterology / Critical Care / Metabolic Disorders

Therapeutic area mix

Electrolyte management / General medicine · 1
Gastroenterology / Critical Care / Metabolic Disorders · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Baptist Health South Florida:

Cite this brief

Drug Landscape (2026). Baptist Health South Florida — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/baptist-health-south-florida. Accessed 2026-05-16.